chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pruritus, Pyrexia, Urticaria
Clinical narrative: Severe hives all over the body, itching, and headache. Fever was there for 5 days straight after the jab
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Breast pain, Dysmenorrhoea, Heavy menstrual bleeding, Hot flush
Clinical narrative: Since 10/13/21 underarm soreness (still present) Since 10/16/2021 have been having daily hot flashes  Starting 12/31 continual breast soreness and nipple sensitivity Heavier than normal menstrual sycle with cramps which never had previously
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Nipple pain, Pain in extremity
Clinical narrative: Since 10/13/21 underarm soreness (still present) Since 10/16/2021 have been having daily hot flashes  Starting 12/31 continual breast soreness and nipple sensitivity Heavier than normal menstrual sycle with cramps which never had previously
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Electrocardiogram, Fatigue, Headache, Myalgia
Clinical narrative: This is a 65 yo F who presents to our facility with concern of myalgias. Symptoms present and worsening over past few days. Unsure of any sick contacts however pt works in a grocery store as chef. Pt also notes diarrhea which she attributes to eggnog a few days ago. Additionally, pt work up with fever this morning with tmax 100.2. She has not taken anything for symptoms. She is vaccinated for COVID however has not received booster as she had a reaction to second vaccine which was lymphadenopathy. She has no other complaints at this time. On examination, patient nontoxic. Chest and lungs are CTA. Afebrile. Await workup. EKG without significant ST or T wave changes.      1158 Covid-19 Result(!): Detected  1203 Pt covid positive. Admitting to HA at this time. Husband at bedside now states he has also been having symptoms of headache and fatigue. Await remainder of workup.  1600 Troponin negative ×2. Patient able to ambulate without evidence of hypoxia. At this time she is stable for discharge. Advised to follow up with primary care physician after quarantine. Return precautions discussed. Pulse ox provided. All questions answered. Patient agreeable to plan.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Troponin normal
Clinical narrative: This is a 65 yo F who presents to our facility with concern of myalgias. Symptoms present and worsening over past few days. Unsure of any sick contacts however pt works in a grocery store as chef. Pt also notes diarrhea which she attributes to eggnog a few days ago. Additionally, pt work up with fever this morning with tmax 100.2. She has not taken anything for symptoms. She is vaccinated for COVID however has not received booster as she had a reaction to second vaccine which was lymphadenopathy. She has no other complaints at this time. On examination, patient nontoxic. Chest and lungs are CTA. Afebrile. Await workup. EKG without significant ST or T wave changes.      1158 Covid-19 Result(!): Detected  1203 Pt covid positive. Admitting to HA at this time. Husband at bedside now states he has also been having symptoms of headache and fatigue. Await remainder of workup.  1600 Troponin negative ×2. Patient able to ambulate without evidence of hypoxia. At this time she is stable for discharge. Advised to follow up with primary care physician after quarantine. Return precautions discussed. Pulse ox provided. All questions answered. Patient agreeable to plan.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acoustic stimulation tests normal, Ear discomfort, Ear pain, Vaccine positive rechallenge
Clinical narrative: After second dose (Jun, 11 2021) started to having ear pain follow by symptoms like airplane ears. First time it last for about two months. Doctor prescribed steroids and antibiotics. Second time started after booster (Dec 27, 2021). Doctor prescribed steroids for six days.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: No adverse effect, dose of 0.3 mL was given by nurse instead of 0.25 mL
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia, Rash
Clinical narrative: Received booster vaccine on 01/13/2022. After vaccine was administered and pt was being observed she developed a rash on her left arm of the injection site and on the back. Was given Benadryl cream by the staff and observed for another 15 mins. Rash improved and she went home. Later in the day she began to have body aches, chills, and a Fever of 101, she took Tylenol and rest with fluids and side effects improved.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Admitted to hospital with breakthrough COVID infection. Symptomatic starting 1/8/22. Admitted to hospital 1/17/22.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Fall, SARS-CoV-2 test positive
Clinical narrative: Fell backwards at a funeral yesterday and was transferred from a facility where she was found to be COVID positive.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac stress test, Chills, Electrocardiogram, Fatigue, Laboratory test
Clinical narrative: Received vaccine in the afternoon.  Woke up in the middle of the night - had chills, aches, tired, heart was pounding. Went to the ER - they did EKG, labs. They had to do a stress test the next AM. Had to see a cardiologist. Started 3 different medications: diltiazem, (cannot remember the other 2)
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Palpitations
Clinical narrative: Received vaccine in the afternoon.  Woke up in the middle of the night - had chills, aches, tired, heart was pounding. Went to the ER - they did EKG, labs. They had to do a stress test the next AM. Had to see a cardiologist. Started 3 different medications: diltiazem, (cannot remember the other 2)
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: Sore Throat . starting 1/15/22
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: periodic itching especially in finger tips.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Dyspnoea, Lung opacity, SARS-CoV-2 test positive
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 01/02/2021.  80 y/o with PMH Hypothyroid, CHF, HTN, Type 1 DM, DVT, DJD, osteoporosis, Hypo-pituitary, HLD, anxiety, spinal stenosis, Hydrocephalus, VP shunt, melanoma presents to ED with c/o worsening SOB.  Pt was recently discharged from hospital Covid +, received Regeneron and 2 days of Remdesivir.  Now requiring O2 at 4L nc.  CXR with bibasilar patchy opacities.  Treated with IV ABX and steroids.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccine breakthrough infection
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 01/02/2021.  80 y/o with PMH Hypothyroid, CHF, HTN, Type 1 DM, DVT, DJD, osteoporosis, Hypo-pituitary, HLD, anxiety, spinal stenosis, Hydrocephalus, VP shunt, melanoma presents to ED with c/o worsening SOB.  Pt was recently discharged from hospital Covid +, received Regeneron and 2 days of Remdesivir.  Now requiring O2 at 4L nc.  CXR with bibasilar patchy opacities.  Treated with IV ABX and steroids.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral, Pruritus
Clinical narrative: Client developed tingling of her lips 10-15 minutes after receiving the vaccine.  Within 10 minutes of receiving Benadryl 50 mg p.o., the itchiness disappeared.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Burning sensation, Condition aggravated, Electromyogram, Insomnia
Clinical narrative: Since I got the booster my peripheral neuropathy has gotten really bad Blood work and tests cannot find the reason.  I am concerned that booster;may be contributing because now i get burning and tingling throughout my body cannot sleep at not and this all began after booster.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Neuropathy peripheral, Paraesthesia
Clinical narrative: Since I got the booster my peripheral neuropathy has gotten really bad Blood work and tests cannot find the reason.  I am concerned that booster;may be contributing because now i get burning and tingling throughout my body cannot sleep at not and this all began after booster.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Pfizer lot #FJ6369 with temp excursion. Reported to Pfizer company and ok?d for use. Instructed by their staff to report each dose given in this system.
Age: 81.0
Sex: M
Vaccine: UNK
Symptoms: COVID-19, Dehydration, Renal injury, SARS-CoV-2 test positive
Clinical narrative: Pt fully vaccinated for COVID. Hospitalized for renal injury and dehydration. Tested positive for COVID upon admission
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: none, patient was given 0.3 mL as booster dose instead of 0.25 mL. No adverse effects.
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute kidney injury, Acute respiratory distress syndrome, COVID-19 pneumonia, Chronic kidney disease, Endotracheal intubation
Clinical narrative: Hospitalized 1/5 transferred to larger hospital on 1/15 hypoxic respiratory failure due to covid pneumonia with refractory ARDS Intubated, mechanically ventilated, sedated and paralyzed, AKI on CKD, prone/supine cycles.
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Mechanical ventilation, Paralysis, Prone position, Respiratory failure, Sedative therapy
Clinical narrative: Hospitalized 1/5 transferred to larger hospital on 1/15 hypoxic respiratory failure due to covid pneumonia with refractory ARDS Intubated, mechanically ventilated, sedated and paralyzed, AKI on CKD, prone/supine cycles.
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, Death, Inappropriate schedule of product administration, SARS-CoV-2 test positive
Clinical narrative: Hospitalized 1/5 transferred to larger hospital on 1/15 hypoxic respiratory failure due to covid pneumonia with refractory ARDS Intubated, mechanically ventilated, sedated and paralyzed, AKI on CKD, prone/supine cycles.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death
Clinical narrative: PT DIED AFTER CONTRACTING COVID-19
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vaginal haemorrhage
Clinical narrative: I am post menopausal, I had not had a period for 12.5 months prior to the 3rd Moderna shot. Now just 1.5 months after that 3rd shot, I am suddenly experiencing very heavy vaginal bleeding.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Anticoagulant therapy, Asthma, Atelectasis
Clinical narrative: ? Principal Problem: Acute on chronic respiratory failure with hypoxia     Overview Note:     Cardiology input:Likely secondary to AECOPD +/- Asthma +/- possible diastolic component of HF Patient with a PFT that showed moderate to severe obstructive disease 2-D echo done 2016 reports an EF of 55-60%, grade 1 diastolic dysfunction, pulmonary hypertension with a PA pressure 31 mmHg Elevated d-dimer 500, age corrected normal, CT PE protocol showed no pulmonary, bibasilar atelectasis   ? COVID-19     Assessment & Plan Note:     83y.o. year old female presents to hospital 12/25 with increasing shortness of breath. The patient was tested for COVID 12/23 and was notified of positive test 12/24 PM. Approximate onset of symptoms of shortness of breath 12/21. Patient was noted to have desaturated to 80% upon EMS arrival however appears stable on 2L O2 /NC at time of my exam. She reports her home O2 is usually 3L/NC due to asthma/COPD, CHF, HTN.  Vaccinated with PFizer 2-4/2021.  CTA : Scattered right-sided pulmonary emboli without evidence of right heart Strain CXR 12/25 atelectasis Patient counseled regarding COVID infection. In view of her stable appearance on baseline O2 requirements I have counseled her regarding Monoclonal antibody and reviewed EUA criteria. She is agreeable with proceeding with treatment. Due to patient not requiring more O2 than baseline O2 requirement she is not a candidate for decadron WRT Covid treatment however will defer to IM if decadron being used as treatment for COPD.     12/27: patient transiently increased to O2 6L, remdesivir initiated with decadron. Rapid return to 2L O2 therefore remdesivir dc'd. Patient on baseline O2 2L with longstanding COPD CTA with PE therefore discharge delayed per IM for anticoagulation S/p MAB
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Chronic obstructive pulmonary disease, Computerised tomogram thorax abnormal, Condition aggravated
Clinical narrative: ? Principal Problem: Acute on chronic respiratory failure with hypoxia     Overview Note:     Cardiology input:Likely secondary to AECOPD +/- Asthma +/- possible diastolic component of HF Patient with a PFT that showed moderate to severe obstructive disease 2-D echo done 2016 reports an EF of 55-60%, grade 1 diastolic dysfunction, pulmonary hypertension with a PA pressure 31 mmHg Elevated d-dimer 500, age corrected normal, CT PE protocol showed no pulmonary, bibasilar atelectasis   ? COVID-19     Assessment & Plan Note:     83y.o. year old female presents to hospital 12/25 with increasing shortness of breath. The patient was tested for COVID 12/23 and was notified of positive test 12/24 PM. Approximate onset of symptoms of shortness of breath 12/21. Patient was noted to have desaturated to 80% upon EMS arrival however appears stable on 2L O2 /NC at time of my exam. She reports her home O2 is usually 3L/NC due to asthma/COPD, CHF, HTN.  Vaccinated with PFizer 2-4/2021.  CTA : Scattered right-sided pulmonary emboli without evidence of right heart Strain CXR 12/25 atelectasis Patient counseled regarding COVID infection. In view of her stable appearance on baseline O2 requirements I have counseled her regarding Monoclonal antibody and reviewed EUA criteria. She is agreeable with proceeding with treatment. Due to patient not requiring more O2 than baseline O2 requirement she is not a candidate for decadron WRT Covid treatment however will defer to IM if decadron being used as treatment for COPD.     12/27: patient transiently increased to O2 6L, remdesivir initiated with decadron. Rapid return to 2L O2 therefore remdesivir dc'd. Patient on baseline O2 2L with longstanding COPD CTA with PE therefore discharge delayed per IM for anticoagulation S/p MAB
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Diastolic dysfunction, Dyspnoea, Echocardiogram abnormal, Ejection fraction normal, Fibrin D dimer increased
Clinical narrative: ? Principal Problem: Acute on chronic respiratory failure with hypoxia     Overview Note:     Cardiology input:Likely secondary to AECOPD +/- Asthma +/- possible diastolic component of HF Patient with a PFT that showed moderate to severe obstructive disease 2-D echo done 2016 reports an EF of 55-60%, grade 1 diastolic dysfunction, pulmonary hypertension with a PA pressure 31 mmHg Elevated d-dimer 500, age corrected normal, CT PE protocol showed no pulmonary, bibasilar atelectasis   ? COVID-19     Assessment & Plan Note:     83y.o. year old female presents to hospital 12/25 with increasing shortness of breath. The patient was tested for COVID 12/23 and was notified of positive test 12/24 PM. Approximate onset of symptoms of shortness of breath 12/21. Patient was noted to have desaturated to 80% upon EMS arrival however appears stable on 2L O2 /NC at time of my exam. She reports her home O2 is usually 3L/NC due to asthma/COPD, CHF, HTN.  Vaccinated with PFizer 2-4/2021.  CTA : Scattered right-sided pulmonary emboli without evidence of right heart Strain CXR 12/25 atelectasis Patient counseled regarding COVID infection. In view of her stable appearance on baseline O2 requirements I have counseled her regarding Monoclonal antibody and reviewed EUA criteria. She is agreeable with proceeding with treatment. Due to patient not requiring more O2 than baseline O2 requirement she is not a candidate for decadron WRT Covid treatment however will defer to IM if decadron being used as treatment for COPD.     12/27: patient transiently increased to O2 6L, remdesivir initiated with decadron. Rapid return to 2L O2 therefore remdesivir dc'd. Patient on baseline O2 2L with longstanding COPD CTA with PE therefore discharge delayed per IM for anticoagulation S/p MAB
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Pulmonary embolism, Pulmonary function test, Pulmonary hypertension, SARS-CoV-2 test positive
Clinical narrative: ? Principal Problem: Acute on chronic respiratory failure with hypoxia     Overview Note:     Cardiology input:Likely secondary to AECOPD +/- Asthma +/- possible diastolic component of HF Patient with a PFT that showed moderate to severe obstructive disease 2-D echo done 2016 reports an EF of 55-60%, grade 1 diastolic dysfunction, pulmonary hypertension with a PA pressure 31 mmHg Elevated d-dimer 500, age corrected normal, CT PE protocol showed no pulmonary, bibasilar atelectasis   ? COVID-19     Assessment & Plan Note:     83y.o. year old female presents to hospital 12/25 with increasing shortness of breath. The patient was tested for COVID 12/23 and was notified of positive test 12/24 PM. Approximate onset of symptoms of shortness of breath 12/21. Patient was noted to have desaturated to 80% upon EMS arrival however appears stable on 2L O2 /NC at time of my exam. She reports her home O2 is usually 3L/NC due to asthma/COPD, CHF, HTN.  Vaccinated with PFizer 2-4/2021.  CTA : Scattered right-sided pulmonary emboli without evidence of right heart Strain CXR 12/25 atelectasis Patient counseled regarding COVID infection. In view of her stable appearance on baseline O2 requirements I have counseled her regarding Monoclonal antibody and reviewed EUA criteria. She is agreeable with proceeding with treatment. Due to patient not requiring more O2 than baseline O2 requirement she is not a candidate for decadron WRT Covid treatment however will defer to IM if decadron being used as treatment for COPD.     12/27: patient transiently increased to O2 6L, remdesivir initiated with decadron. Rapid return to 2L O2 therefore remdesivir dc'd. Patient on baseline O2 2L with longstanding COPD CTA with PE therefore discharge delayed per IM for anticoagulation S/p MAB
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Papule, Pruritus, Rash, Rash pruritic, Skin exfoliation
Clinical narrative: Developed pruritic scalp few hours after vaccine. Next day rash on chest and back. Rash is pruritic. Described as salmon colored, scaly, papules and patches on chest and back.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Autoimmune disorder, Blood creatine phosphokinase, Blood creatinine, Blood pressure fluctuation, Blood test
Clinical narrative: Started feeling tingling and numbing sensation in foot weeks after and sever muscle weakness 2 to 3 months after. Was admitted to hospital in August due to irregular heart beat and fluctuated blood pressure. Was treated for autoimmune disease in August by taking Prednizone and medication that regulates the heart beat
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate irregular, Hypoaesthesia, Laboratory test, Muscular weakness, Paraesthesia
Clinical narrative: Started feeling tingling and numbing sensation in foot weeks after and sever muscle weakness 2 to 3 months after. Was admitted to hospital in August due to irregular heart beat and fluctuated blood pressure. Was treated for autoimmune disease in August by taking Prednizone and medication that regulates the heart beat
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19 pneumonia, Diarrhoea, Dyspnoea, Pain in extremity
Clinical narrative: Hospitalized 01/09/2022; COVID-19 positive 01/09/2022; fully vaccinated  Discharge Provider:  Primary Care Provider: DO Admission Date: 1/9/2022 Discharge Date: Jan 13, 2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute hypoxemic respiratory failure due to COVID-19 [U07.1, J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 52 y.o. male with past medical history significant for ETOH mediated cirrhosis, hx etoh use disorder in remission, chronic pancreatis with history necrotizing pancreatitis and pseudocyst briefly previously PGJ tube (removed 2017), portal vein thrombosis on warfarin, acquired type 1 diabetes mellitus secondary to pancreatitis, mild persistent asthma, active tobacco use disorder and chronic low back pain with chronic narcotic dependence who presents to the emergency room two days after testing positive for COVID 19 with worsening shortness of breath. He is fully vaccinated (3/2021) but not boosted. Patient was treated for COVID-19 pneumonia.  Patient required oxygen.  Completed a course of remdesivir while inpatient.  Was started on Decadron steroids, patient doing well and his O2 requirements stabilized for several days prior to discharge.  Pulmonary rehab was consulted and arranged home oxygen for home.  Management also arranged for patient to be enrolled in the COVID at home program for continued follow-up after discharge. Currently, patient was noted to have bilateral cavitary lung nodules and community-acquired pneumonia.  Pulmonology was consulted.  He was started on IV antibiotics.  Again, his respiratory status improved and patient was to complete a total 7 day course of IV antibiotics.  He he was also advised to follow up with a CT scan in the outpatient setting in 3 months.  This was noted in his discharge paperwork. Patient also developed bilateral thigh pain.  There was not a clear etiology of his symptoms but he was on atorvastatin which has a known side effect of myalgias.  This was discontinued on discharge. Patient also noted loose stools and reported history of greasy stools at home.  He was started on pancreatic enzyme replacement.  He was given prescriptions for this on discharge.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pneumonia, Pulmonary mass, Steatorrhoea
Clinical narrative: Hospitalized 01/09/2022; COVID-19 positive 01/09/2022; fully vaccinated  Discharge Provider:  Primary Care Provider: DO Admission Date: 1/9/2022 Discharge Date: Jan 13, 2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute hypoxemic respiratory failure due to COVID-19 [U07.1, J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 52 y.o. male with past medical history significant for ETOH mediated cirrhosis, hx etoh use disorder in remission, chronic pancreatis with history necrotizing pancreatitis and pseudocyst briefly previously PGJ tube (removed 2017), portal vein thrombosis on warfarin, acquired type 1 diabetes mellitus secondary to pancreatitis, mild persistent asthma, active tobacco use disorder and chronic low back pain with chronic narcotic dependence who presents to the emergency room two days after testing positive for COVID 19 with worsening shortness of breath. He is fully vaccinated (3/2021) but not boosted. Patient was treated for COVID-19 pneumonia.  Patient required oxygen.  Completed a course of remdesivir while inpatient.  Was started on Decadron steroids, patient doing well and his O2 requirements stabilized for several days prior to discharge.  Pulmonary rehab was consulted and arranged home oxygen for home.  Management also arranged for patient to be enrolled in the COVID at home program for continued follow-up after discharge. Currently, patient was noted to have bilateral cavitary lung nodules and community-acquired pneumonia.  Pulmonology was consulted.  He was started on IV antibiotics.  Again, his respiratory status improved and patient was to complete a total 7 day course of IV antibiotics.  He he was also advised to follow up with a CT scan in the outpatient setting in 3 months.  This was noted in his discharge paperwork. Patient also developed bilateral thigh pain.  There was not a clear etiology of his symptoms but he was on atorvastatin which has a known side effect of myalgias.  This was discontinued on discharge. Patient also noted loose stools and reported history of greasy stools at home.  He was started on pancreatic enzyme replacement.  He was given prescriptions for this on discharge.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Fatigue, Hypertension
Clinical narrative: Extremely high blood pressure levels, extreme fatigue, shortness of breath, and dizzy spells
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: none, patient was given 0.3 mL of Moderna booster instead of 0.25 mL
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Client came in seeking Moderna booster at age 17 and staff failed to screen him out for this. Moderna booster was given
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Alanine aminotransferase increased, Blood chloride increased, Blood glucose normal, Blood thyroid stimulating hormone normal, Brain natriuretic peptide normal
Clinical narrative: 3+ pitting edema and tachycardia (114-140 beats per minute) Patient sent to emergency department for evaluation.   Recommendation for compression stockings
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram thorax abnormal, Fibrin D dimer increased, Full blood count, Liver function test increased, Metabolic function test
Clinical narrative: 3+ pitting edema and tachycardia (114-140 beats per minute) Patient sent to emergency department for evaluation.   Recommendation for compression stockings
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Oedema, Pleural effusion, Red blood cell count decreased, Red cell distribution width increased, Tachycardia
Clinical narrative: 3+ pitting edema and tachycardia (114-140 beats per minute) Patient sent to emergency department for evaluation.   Recommendation for compression stockings
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Troponin normal, Ultrasound scan normal
Clinical narrative: 3+ pitting edema and tachycardia (114-140 beats per minute) Patient sent to emergency department for evaluation.   Recommendation for compression stockings
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Cough, Death, Dyspnoea, General physical health deterioration
Clinical narrative: Pt had a medical history of diabetes and presented with shortness of breath.  He also has cough, fevers, weakness and muscle aches.  Pt deteriorated quickly and passed on 1/17/2022.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Pt had a medical history of diabetes and presented with shortness of breath.  He also has cough, fevers, weakness and muscle aches.  Pt deteriorated quickly and passed on 1/17/2022.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: patient hospitalized 1/17/22 with covid 19 after immunization
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, Alanine aminotransferase increased, Aspartate aminotransferase increased, Asthenia, Back pain
Clinical narrative: Administered by Facility. Unable to retrieve lot numbers. Only injection dates were provided. 80-year-old male who was in the high care living center connected to the hospital here.  Patient recently in the emergency room for acute kidney injury.  Patient receiving fluids as of yesterday.  Reviewing patient's history and laboratories patient with a left lower lobe infiltrate on chest x-ray on 14 January 2022.  Patient brought over to the emergency room today because patient is hypotensive and weak with increasing oxygen demand.  Patient complaining of some mild back pain earlier no back pain now.  Denies nausea or vomiting denies abdominal pain.  Denies trauma fall or injury.  Patient brought over for further evaluation secondary to hypotension
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Bacteriuria, Blood alkaline phosphatase increased, Blood bicarbonate decreased, Blood creatinine increased, Blood pH decreased
Clinical narrative: Administered by Facility. Unable to retrieve lot numbers. Only injection dates were provided. 80-year-old male who was in the high care living center connected to the hospital here.  Patient recently in the emergency room for acute kidney injury.  Patient receiving fluids as of yesterday.  Reviewing patient's history and laboratories patient with a left lower lobe infiltrate on chest x-ray on 14 January 2022.  Patient brought over to the emergency room today because patient is hypotensive and weak with increasing oxygen demand.  Patient complaining of some mild back pain earlier no back pain now.  Denies nausea or vomiting denies abdominal pain.  Denies trauma fall or injury.  Patient brought over for further evaluation secondary to hypotension
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood urea increased, C-reactive protein increased, COVID-19, Chest X-ray abnormal, Haemoglobin normal
Clinical narrative: Administered by Facility. Unable to retrieve lot numbers. Only injection dates were provided. 80-year-old male who was in the high care living center connected to the hospital here.  Patient recently in the emergency room for acute kidney injury.  Patient receiving fluids as of yesterday.  Reviewing patient's history and laboratories patient with a left lower lobe infiltrate on chest x-ray on 14 January 2022.  Patient brought over to the emergency room today because patient is hypotensive and weak with increasing oxygen demand.  Patient complaining of some mild back pain earlier no back pain now.  Denies nausea or vomiting denies abdominal pain.  Denies trauma fall or injury.  Patient brought over for further evaluation secondary to hypotension
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hyporesponsive to stimuli, Hypotension, Leukocytosis, Lung infiltration, Muscular weakness
Clinical narrative: Administered by Facility. Unable to retrieve lot numbers. Only injection dates were provided. 80-year-old male who was in the high care living center connected to the hospital here.  Patient recently in the emergency room for acute kidney injury.  Patient receiving fluids as of yesterday.  Reviewing patient's history and laboratories patient with a left lower lobe infiltrate on chest x-ray on 14 January 2022.  Patient brought over to the emergency room today because patient is hypotensive and weak with increasing oxygen demand.  Patient complaining of some mild back pain earlier no back pain now.  Denies nausea or vomiting denies abdominal pain.  Denies trauma fall or injury.  Patient brought over for further evaluation secondary to hypotension
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Platelet count decreased, Positive airway pressure therapy, SARS-CoV-2 test positive, Thrombocytopenia, Urine analysis abnormal
Clinical narrative: Administered by Facility. Unable to retrieve lot numbers. Only injection dates were provided. 80-year-old male who was in the high care living center connected to the hospital here.  Patient recently in the emergency room for acute kidney injury.  Patient receiving fluids as of yesterday.  Reviewing patient's history and laboratories patient with a left lower lobe infiltrate on chest x-ray on 14 January 2022.  Patient brought over to the emergency room today because patient is hypotensive and weak with increasing oxygen demand.  Patient complaining of some mild back pain earlier no back pain now.  Denies nausea or vomiting denies abdominal pain.  Denies trauma fall or injury.  Patient brought over for further evaluation secondary to hypotension
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: White blood cell count increased, White blood cells urine positive
Clinical narrative: Administered by Facility. Unable to retrieve lot numbers. Only injection dates were provided. 80-year-old male who was in the high care living center connected to the hospital here.  Patient recently in the emergency room for acute kidney injury.  Patient receiving fluids as of yesterday.  Reviewing patient's history and laboratories patient with a left lower lobe infiltrate on chest x-ray on 14 January 2022.  Patient brought over to the emergency room today because patient is hypotensive and weak with increasing oxygen demand.  Patient complaining of some mild back pain earlier no back pain now.  Denies nausea or vomiting denies abdominal pain.  Denies trauma fall or injury.  Patient brought over for further evaluation secondary to hypotension
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Gait disturbance, Pain, Paraesthesia
Clinical narrative: Extreme weakness, joints and muscles not wanting to function or hold me up. I often need a cane. I am not able to walk far without holding onto something. Pain levels are higher. This started within 24 hours and progressed to its worst within 2 weeks. It's been 18 days and the "buzzing" is at an all time high in my nerves. I haven't contacted a doctor because of the long-term small fiber neuropathy and moving. I do not have a GP set until Feb 4th. I am avoiding people due to the spread of Omicron and COVID-19. Going to call for an earlier appointment.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, COVID-19, Dyspnoea, Echocardiogram normal, Ejection fraction normal
Clinical narrative: HOSPITAL COURSE: This is 67 years old female with history of paroxsymal atrial fibrillation diagnosed on March 2021.  She was placed on Xarelto with instruction to follow-up with cardiology in 6 weeks to review Zio result.  PTA Pt decided Not taking anticoagulation. She also has hx of breast cancer, status post lumpectomy and radiation, lymphoma status post chemo treatment and depression. She has not kept her outpt follow up appt with oncology.  patient test positive for COVID-19 on 12/28.  Pt presented to the ED with a complaint of shortness of breath.  She found to have bilateral PE.  Echo with nl EF, no pulm HTN.  Initially patient was started on heparin infusion.  Then we transition her to oral anticoagulation Xarelto, we also started patient on dexamethasone for her recent COVID-19 infection.  Gradually her respiratory failure hypoxia resolved. Pulmonary embolism and infarction (HCC) Today patient will be discharged home.  At the time of discharge patient no longer has hypoxia
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Infusion, Pulmonary embolism, Pulmonary infarction, Respiratory failure
Clinical narrative: HOSPITAL COURSE: This is 67 years old female with history of paroxsymal atrial fibrillation diagnosed on March 2021.  She was placed on Xarelto with instruction to follow-up with cardiology in 6 weeks to review Zio result.  PTA Pt decided Not taking anticoagulation. She also has hx of breast cancer, status post lumpectomy and radiation, lymphoma status post chemo treatment and depression. She has not kept her outpt follow up appt with oncology.  patient test positive for COVID-19 on 12/28.  Pt presented to the ED with a complaint of shortness of breath.  She found to have bilateral PE.  Echo with nl EF, no pulm HTN.  Initially patient was started on heparin infusion.  Then we transition her to oral anticoagulation Xarelto, we also started patient on dexamethasone for her recent COVID-19 infection.  Gradually her respiratory failure hypoxia resolved. Pulmonary embolism and infarction (HCC) Today patient will be discharged home.  At the time of discharge patient no longer has hypoxia
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: HOSPITAL COURSE: This is 67 years old female with history of paroxsymal atrial fibrillation diagnosed on March 2021.  She was placed on Xarelto with instruction to follow-up with cardiology in 6 weeks to review Zio result.  PTA Pt decided Not taking anticoagulation. She also has hx of breast cancer, status post lumpectomy and radiation, lymphoma status post chemo treatment and depression. She has not kept her outpt follow up appt with oncology.  patient test positive for COVID-19 on 12/28.  Pt presented to the ED with a complaint of shortness of breath.  She found to have bilateral PE.  Echo with nl EF, no pulm HTN.  Initially patient was started on heparin infusion.  Then we transition her to oral anticoagulation Xarelto, we also started patient on dexamethasone for her recent COVID-19 infection.  Gradually her respiratory failure hypoxia resolved. Pulmonary embolism and infarction (HCC) Today patient will be discharged home.  At the time of discharge patient no longer has hypoxia
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Pfizer lot #FJ6369 with temp excursion. Reported to Pfizer company and ok?d for use. Instructed by their staff to report each dose given in this system.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives.
Age: 90.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Mental status changes, SARS-CoV-2 test positive
Clinical narrative: 12/28/21 presents to EC ED for "altered mental status". PMHx of "hypertension dementia"
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Admitted to hospital with breakthrough COVID infection 1/17/22
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Psoriasis
Clinical narrative: patient reported her psoriasis flared up after receiving 1st dose, she did not receive the 2nd dose
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: hospitalization
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Nasal congestion, Oropharyngeal pain
Clinical narrative: DIAGNOSED WITH COVID 1/15/2022 - NASAL CONGESTION, COUGH, SORE THROAT, JANSSEN ON 04/07/2021
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood test, Fatigue, Feeling abnormal, HIV test
Clinical narrative: Headache, nausea, extreme tiredness (falling asleep randomly), weakness,  extreme brain fog, higher than normal heart rate when exercising.   Symptoms lasted almost 4 months. Headache and nausea began to subside in the 2-3 month range. Fatigue continued for about 4 months, same with the brain fog.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Heart rate increased, Laboratory test, Nausea, Somnolence
Clinical narrative: Headache, nausea, extreme tiredness (falling asleep randomly), weakness,  extreme brain fog, higher than normal heart rate when exercising.   Symptoms lasted almost 4 months. Headache and nausea began to subside in the 2-3 month range. Fatigue continued for about 4 months, same with the brain fog.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Stool analysis
Clinical narrative: Headache, nausea, extreme tiredness (falling asleep randomly), weakness,  extreme brain fog, higher than normal heart rate when exercising.   Symptoms lasted almost 4 months. Headache and nausea began to subside in the 2-3 month range. Fatigue continued for about 4 months, same with the brain fog.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray, Chest pain, Diarrhoea, Dizziness, Dyspnoea
Clinical narrative: Immediately after the shot I became dizzy and had the feeling of having drank several drinks and had a buzz.  My left arm was very sore this time and hurt to touch or lift it up.  The following day I began to have headaches and body aches and had a fever.  My fever lasted for 5 days and my fever on Sunday stayed in the 103 range.  On Monday, I had diarrhea for most of the day.  I tried getting into the doctor and the soonest I could find an appointment was Wednesday morning, 1/12/2022.  The fever, body aches, headache, shortness of breath and lethargic feeling continued through Wednesday. At Urgent care I was given a Covid and Flu test, however it was a 2-4 day turnaround.   Then on Thursday morning, 1/13/2022, I went to the ER with chest pains and shortness of breath.  There they gave me a covid and flu test and both of those came up negative.  Everything looked good on my EKG and chest X-ray and I was told that this was probably all from the booster shot.  I didn't start to feel better until, Saturday, 1/15/2022; which was a week and a day after the booster shot was administered.  I was called yesterday, Monday, 1/17/2022, from  Urgent Care and my Covid test results from Wednesday also came back negative.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram, Feeling drunk, Headache, Immediate post-injection reaction, Influenza virus test negative
Clinical narrative: Immediately after the shot I became dizzy and had the feeling of having drank several drinks and had a buzz.  My left arm was very sore this time and hurt to touch or lift it up.  The following day I began to have headaches and body aches and had a fever.  My fever lasted for 5 days and my fever on Sunday stayed in the 103 range.  On Monday, I had diarrhea for most of the day.  I tried getting into the doctor and the soonest I could find an appointment was Wednesday morning, 1/12/2022.  The fever, body aches, headache, shortness of breath and lethargic feeling continued through Wednesday. At Urgent care I was given a Covid and Flu test, however it was a 2-4 day turnaround.   Then on Thursday morning, 1/13/2022, I went to the ER with chest pains and shortness of breath.  There they gave me a covid and flu test and both of those came up negative.  Everything looked good on my EKG and chest X-ray and I was told that this was probably all from the booster shot.  I didn't start to feel better until, Saturday, 1/15/2022; which was a week and a day after the booster shot was administered.  I was called yesterday, Monday, 1/17/2022, from  Urgent Care and my Covid test results from Wednesday also came back negative.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Lethargy, Pain, Pain in extremity, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: Immediately after the shot I became dizzy and had the feeling of having drank several drinks and had a buzz.  My left arm was very sore this time and hurt to touch or lift it up.  The following day I began to have headaches and body aches and had a fever.  My fever lasted for 5 days and my fever on Sunday stayed in the 103 range.  On Monday, I had diarrhea for most of the day.  I tried getting into the doctor and the soonest I could find an appointment was Wednesday morning, 1/12/2022.  The fever, body aches, headache, shortness of breath and lethargic feeling continued through Wednesday. At Urgent care I was given a Covid and Flu test, however it was a 2-4 day turnaround.   Then on Thursday morning, 1/13/2022, I went to the ER with chest pains and shortness of breath.  There they gave me a covid and flu test and both of those came up negative.  Everything looked good on my EKG and chest X-ray and I was told that this was probably all from the booster shot.  I didn't start to feel better until, Saturday, 1/15/2022; which was a week and a day after the booster shot was administered.  I was called yesterday, Monday, 1/17/2022, from  Urgent Care and my Covid test results from Wednesday also came back negative.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: none, patient was given 0.3 mL in error instead of 0.25 mL booster
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cough, Diarrhoea, Dizziness, Headache, Insomnia
Clinical narrative: Diarrhea (2 days),  sore throat (several days),  headaches (2 days),  dizziness (2 days),  loss of sleep (14 days) cough (7 days)
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: Diarrhea (2 days),  sore throat (several days),  headaches (2 days),  dizziness (2 days),  loss of sleep (14 days) cough (7 days)
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, SARS-CoV-2 test positive
Clinical narrative: Patient stated they received the Pfizer 2 shot series and the booster.  Unable to obtain dates nor place of vaccine administration..
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMRV
Symptoms: Diarrhoea, Erythema, Peripheral swelling, Vomiting
Clinical narrative: L arm red, swollen and 1/2'' "bubbling.  No fever, SOB, V/D began 48 hrs after vaccination
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Pfizer lot #FJ6369 with temp excursion. Reported to Pfizer company and ok?d for use. Instructed by their staff to report each dose given in this system.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cardiac failure congestive, Chest X-ray abnormal, Cough, Dyspnoea
Clinical narrative: Covid19 breakthrough.  Vaccinated on 7/31/2021.  69 yo PMH Asthma, HTN, CKD, MDD, PTSD, arthritis, Right eye removal, AV replacement originally tested Covid + 2 weeks ago, retested 1 week ago and still positive.  Pt was trying to manage symptoms at home but presented to ER after 4 days of worsening SOB and coughing.  O2 sats at home 60's.  CXR-mild CHF.  Treated with Steroids and Remdesivir.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Covid19 breakthrough.  Vaccinated on 7/31/2021.  69 yo PMH Asthma, HTN, CKD, MDD, PTSD, arthritis, Right eye removal, AV replacement originally tested Covid + 2 weeks ago, retested 1 week ago and still positive.  Pt was trying to manage symptoms at home but presented to ER after 4 days of worsening SOB and coughing.  O2 sats at home 60's.  CXR-mild CHF.  Treated with Steroids and Remdesivir.
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Computerised tomogram normal, Deep vein thrombosis, Fibrin D dimer increased, Superficial vein thrombosis, Ultrasound Doppler abnormal
Clinical narrative: DVT lower right leg, behind calf, distal to knee, with extraneous SVT in upper right thigh
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Pfizer lot #FJ6369 with temp excursion. Reported to Pfizer company and ok?d for use. Instructed by their staff to report each dose given in this system.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Audiogram normal, Dizziness
Clinical narrative: I took the J&J Jansen initial vaccine on April 8th 2021.  This vaccine was the booster shot from Pfizer.  I received the booster on 1-7-2020.  Three days later I woke up and felt extremely dizzy and lite headed.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Dyspnoea, Hypervolaemia, Illness
Clinical narrative: Hospitalized with worsening dyspnea and O2 sats of 65% in ED. Acute respiratory failure, volume overload (missed dialysis appt),  COVID + on 1/6/2022.  COVID probably not as contributory to illness as missed dialysis session.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Therapy interrupted
Clinical narrative: Hospitalized with worsening dyspnea and O2 sats of 65% in ED. Acute respiratory failure, volume overload (missed dialysis appt),  COVID + on 1/6/2022.  COVID probably not as contributory to illness as missed dialysis session.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea
Clinical narrative: Pt has had increasing shortness of breath.  Pt was recently hospitalized for heart failure and discharged on 1/13.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered dose after use date.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Hypoaesthesia oral, Paraesthesia
Clinical narrative: The day after getting the booster shot, I started experiencing pins and needles and numbness in my left thumb and it has since spread daily up my entire arm, left leg from my knee down and the left side of my faced and tongue. I felt like my face was sagging last week.  My Primary care dr didn't see me since they have no list of adverse reactions.  I dont know what to do at this point.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Gastric bypass, Vomiting
Clinical narrative: Pt fully vaccinated for COVID. Received Moderna. Unknown dates. Pt admitted with abdominal pain and vomiting. Did receive gastric bypass revision 12/2021
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: I tested positive for COVID19 on 01/05/2022 despite being fully vaccinated. I started feeling sick around 12/30/2021 but never got tested until 01/05/2022. Symptoms were mild and I still had my sense of smell and taste.